70,128 Cardinal Health, Inc. $CAH Shares Bought by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 102.0% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 138,853 shares of the company’s stock after purchasing an additional 70,128 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Cardinal Health were worth $30,895,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $6,293,115,000. Wellington Management Group LLP increased its position in Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after purchasing an additional 10,584,119 shares during the last quarter. Bank of America Corp DE purchased a new stake in Cardinal Health during the second quarter valued at $689,066,000. Victory Capital Management Inc. raised its stake in Cardinal Health by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 2,698,189 shares of the company’s stock valued at $554,478,000 after purchasing an additional 414,074 shares in the last quarter. Finally, Legal & General Group Plc bought a new position in Cardinal Health during the second quarter valued at $438,870,000. Institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling

In other Cardinal Health news, insider Jessica Mayer sold 29,436 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares in the company, valued at $7,812,220.44. This represents a 47.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason Hollar sold 44,529 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the sale, the chief executive officer directly owned 190,603 shares of the company’s stock, valued at $45,016,616.54. This represents a 18.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 210,271 shares of company stock worth $49,626,657 over the last 90 days. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Stock Up 3.0%

CAH opened at $239.15 on Friday. The business has a fifty day moving average of $233.39 and a 200 day moving average of $220.75. The stock has a market cap of $55.38 billion, a P/E ratio of 33.08, a PEG ratio of 1.40 and a beta of 0.50. Cardinal Health, Inc. has a 52-week low of $151.87 and a 52-week high of $258.30.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research reports. Evercore restated an “outperform” rating and issued a $270.00 target price on shares of Cardinal Health in a report on Wednesday, August 12th. TD Cowen increased their price target on shares of Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a report on Thursday, August 13th. Robert W. Baird lifted their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 12th. Royal Bank Of Canada initiated coverage on Cardinal Health in a research note on Wednesday, August 19th. They set an “outperform” rating and a $276.00 price objective on the stock. Finally, Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $266.56.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.